International Journal of Medicine and Data

Objective To study the effective value of ECMO (extracorporeal membrane oxygenation) in the treatment of severe pneumonia. Methods 88 severe pneumonia patients diagnosed between October 2022 and December 2023 were included in the observation range. Two groups were divided using a digital table method, namely the basic intervention group of basic mechanical ventilation intervention and the oxygenation intervention group of extracorporeal membrane oxygenation intervention. The changes in physical indicators and treatment effects of the two groups were compared. Results In the oxygenation intervention group, 16 patients had a significant improvement in their condition, 25 patients had a general improvement in their condition, and 3 patients had no improvement in their condition. The improvement rate was 93.2%, which was higher than 86.4% in the basic intervention group (p<0.05); After treatment, the mean oxygenation index (11.25 ± 3.40)%, mean blood oxygen partial pressure (54.78 ± 5.18) mmHg, mean carbon dioxide partial pressure (51.45 ± 3.55) mmHg, and mean airway resistance (40.55 ± 4.67) cmH2O/(L · s) in the oxygenation intervention group were all better than those in the basic intervention group, p<0.05; The incidence of adverse reactions in the oxygenation intervention group was 4.6%, which was lower than 11.4% in the basic intervention group (2 cases of infection, 2 cases of gastrointestinal discomfort, and 1 case of abnormal pain), p<0.05. Conclusion In the treatment of severe pneumonia, ECMO technology should be introduced in a timely manner to increase the improvement rate of the condition, promote the improvement of respiratory indicators, and ensure the safety of treatment.

Extracorporeal membrane oxygenation; Severe pneumonia; Respiratory indicators; Adverse reactions